Stockscreener 앱 받기
7.48
0.54%
0.04
시간 외 거래:
6.66
-0.82
-10.96%
전일 마감가:
$7.44
열려 있는:
$6.77
하루 거래량:
384.00K
Relative Volume:
0.83
시가총액:
$11.85M
수익:
-
순이익/손실:
$-14.58M
주가수익비율:
-6.5043
EPS:
-1.15
순현금흐름:
$-9.80M
1주 성능:
+64.40%
1개월 성능:
+83.78%
6개월 성능:
+11.48%
1년 성능:
-82.02%
1일 변동 폭
$6.75
$7.65
1주일 범위
$4.10
$8.34
52주 변동 폭
$3.80
$42.80
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
명칭
Acurx Pharmaceuticals Inc
전화
917-533-1469
주소
259 LIBERTY AVENUE, STATEN ISLAND
ACXP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
7.48 | 11.79M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Acurx Pharmaceuticals Inc 주식(ACXP)의 최신 뉴스
Acurx Pharmaceuticals Inc.’s volatility index tracking explainedMarket Volume Summary & Weekly Momentum Stock Picks - newser.com
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Myrtle Beach Sun News
Acurx Pharmaceuticals (NASDAQ:ACXP) Raised to Hold at Wall Street Zen - Defense World
How Acurx Pharmaceuticals Inc. (3ZO) stock reacts to fiscal policiesWeekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com
Acurx Pharmaceuticals granted Australian patent for antibiotics - Investing.com Australia
Acurx Pharmaceuticals granted Australian patent for antibiotics By Investing.com - Investing.com Nigeria
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - Stock Titan
Measuring Acurx Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Levels & Verified Swing Trading Watchlist - newser.com
What drives Acurx Pharmaceuticals Inc stock pricePrice-to-Earnings Ratio Insights & High Return Market Tips - earlytimes.in
Pharma Boom: Acurx on the Rise - StocksToTrade
ACXP’s Steady Climb: New Developments? - timothysykes.com
90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions - ts2.tech
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Corpus Christi Caller-Times
Will breakout in Acurx Pharmaceuticals Inc. lead to full recoveryPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com
Acurx Pharmaceuticals Inc Stock Analysis and ForecastInterest Rate Changes & Build Capital Safely - earlytimes.in
How supply shortages influence Acurx Pharmaceuticals Inc. (3ZO) stockInsider Buying & Weekly Stock Performance Updates - newser.com
Acurx Pharmaceuticals Inc. stock trendline breakdownChart Signals & Long-Term Investment Growth Plans - newser.com
Why retail investors favor Acurx Pharmaceuticals Inc. stockPortfolio Gains Report & Reliable Breakout Stock Forecasts - newser.com
Will Acurx Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - newser.com
New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST - Sacramento Bee
Acurx Pharmaceuticals (NASDAQ:ACXP) Lowered to Sell Rating by Wall Street Zen - Defense World
Will Acurx Pharmaceuticals Inc. (3ZO) stock return to pre crash levels2025 Price Action Summary & Comprehensive Market Scan Insights - newser.com
Can Acurx Pharmaceuticals Inc. (3ZO) stock test all time highsEarnings Summary Report & High Yield Equity Trading Tips - newser.com
Chart overlay techniques for tracking Acurx Pharmaceuticals Inc.2025 Support & Resistance & Consistent Profit Alerts - newser.com
Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Nigeria
Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright - Investing.com
EMA approves Acurx’s pediatric plan for C. difficile drug ibezapolstat By Investing.com - Investing.com Nigeria
Acurx Pharmaceuticals (NASDAQ:ACXP) Given “Buy” Rating at HC Wainwright - Defense World
H.C. Wainwright Maintains Acurx Pharmaceuticals(ACXP.US) With Buy Rating, Maintains Target Price $31 - 富途牛牛
Promising Outlook for Acurx Pharmaceuticals: Buy Rating Driven by Regulatory Milestones and Clinical Success of Ibezapolstat - TipRanks
EMA approves Acurx’s pediatric plan for C. difficile drug ibezapolstat - Investing.com
Acurx Pharmaceuticals, Inc. Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. Difficile Infection - MarketScreener
DYAI Stock Analysis and ForecastVolume Profile Analysis & Start Investing With Free Smart Watchlists - earlytimes.in
20,000 Children Affected Annually: Acurx's New Antibiotic Gets Key EMA Support for C. difficile Treatment - Stock Titan
Acurx Pharmaceuticals Inc (ACXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Acurx Pharmaceuticals Inc 주식 (ACXP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sailer Carl | Director |
Jan 06 '25 |
Buy |
1.01 |
24,631 |
25,000 |
137,183 |
| LUCI DAVID P | President and CEO |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,097,458 |
| Donohue James J. | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
22,352 |
| DELUCCIA ROBERT J | Director |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,010,196 |
| DEAN JACK H | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
21,776 |
5.74%
자본화:
|
볼륨(24시간):